Adona Medical Secures $33.5 Million in Series C Funding for Heart Failure Solution
| | | | |

Adona Medical Secures $33.5 Million in Series C Funding for Heart Failure Solution

Adona Medical, a Shifamed portfolio company specializing in advanced solutions for heart failure, has successfully secured $33.5 million in Series C financing. The funding will support the next stage of product development and early clinical experience for their novel interatrial shunt and remote monitoring solution designed for patients with heart failure. The financing round was…

Maximum Fidelity Surgical Simulations Raises $2.25 Million in Seed Funding Round
| | |

Maximum Fidelity Surgical Simulations Raises $2.25 Million in Seed Funding Round

Maximum Fidelity Surgical Simulations (MaxFi), founded in 2014 by Joss Fernandez, MD, FACS, is a company that provides lifelike cadavers for highly realistic surgical simulations in medical education, research, and military training. The companys patented and proprietary cadaver perfusion system allows cadavers to simulate physiological conditions like bleeding, breathing, and handling like live patients. MaxFis…

Alpha Capital Anstalt Acquires ENvizion Medical Ltd., Expanding Its Presence in the Medical Technology Market
| | |

Alpha Capital Anstalt Acquires ENvizion Medical Ltd., Expanding Its Presence in the Medical Technology Market

Alpha Capital Anstalt, a renowned investor, has completed the acquisition of all operating assets and IP of ENvizion Medical Ltd., including ENvizion Medical Inc., a pioneer in enteral feeding tube navigation technology. ENvizion Medical Inc. will operate as a privately held entity following the transaction, focusing on its advanced ENvue system for precise feeding tube…

Amsino Medical Group Secures Transformational Investment from Novo Tellus
| | | | |

Amsino Medical Group Secures Transformational Investment from Novo Tellus

Amsino Medical Group, a global provider of medical consumable devices, has announced a significant investment from Novo Tellus, a leading investment firm specializing in longterm investments in the global supply chain. Novo Tellus, who previously partnered with Amsino from 2011 to 2017, is deeply familiar with Amsinos operations. The investment aims to support Amsinos global…

Endogenex Closes $88 Million Series C Funding Round
| | |

Endogenex Closes $88 Million Series C Funding Round

Endogenex, a clinicalstage medical device company focused on improving outcomes for individuals with type 2 diabetes, has successfully closed an oversubscribed Series C funding round totaling $88 million. The funding will be utilized to complete the pivotal ReCET Clinical Study, which has received FDA approval under an Investigational Device Exemption (IDE). The Series C funding…

Axena Health Closes $9.4M Series A Funding Round
| | | |

Axena Health Closes $9.4M Series A Funding Round

Axena Health, a medical device company specializing in female pelvic health, has successfully closed a Series A funding round, raising an additional $9.4 million. The funding will be utilized to support the companys growth initiatives both in the United States and internationally. In the U.S., Axena Health will focus on the continued commercial launch of…

BD Acquires Edwards Lifesciences Critical Care Product Group for $4.2 Billion
| | |

BD Acquires Edwards Lifesciences Critical Care Product Group for $4.2 Billion

BD (Becton, Dickinson and Company) has announced the acquisition of Edwards Lifesciences Critical Care product group for $4.2 billion in cash. The Critical Care product group is a global leader in advanced monitoring solutions, with a focus on hemodynamic monitoring and medication management technologies. This acquisition enhances BDs portfolio of smart connected care solutions and…

CereVasc, Inc. Completes $70 Million Series B Financing
| | | |

CereVasc, Inc. Completes $70 Million Series B Financing

CereVasc, Inc., a clinicalstage medical device company based in Massachusetts, has successfully completed the initial closing of a $70 million Series B financing round. The funding will support the clinical development of the eShunt System, including the upcoming STRIDE pivotal study in patients with Normal Pressure Hydrocephalus. The STRIDE trial aims to assess the safety…

Aardvark Therapeutics, Inc. Secures $85 Million in Series C Funding
| | | | |

Aardvark Therapeutics, Inc. Secures $85 Million in Series C Funding

Aardvark Therapeutics, Inc. has announced the completion of an $85 million oversubscribed Series C financing round led by Decheng Capital, with participation from a syndicate of new and existing investors. The company is a clinicalstage biopharmaceutical firm focused on developing innovative smallmolecule therapeutics for the treatment of metabolic diseases and inflammation. The funding will be…

Nanochon Raises $4 Million in Series Seed Prime Fundraising Round
| | | |

Nanochon Raises $4 Million in Series Seed Prime Fundraising Round

Nanochon, a Washington, DCbased orthopedic device biotech company, has secured $4 million in its series seed prime fundraising round. The funding will be utilized to launch the companys first in human clinical trials in the US in 2024, intensify research and development efforts, bolster the company’s patent portfolio, and expand its team. The funding round…